Prevalence and clinicopathologic characteristics of gastric cardia cancer in south korea

Helicobacter

Volumn 17, Issue 5, 2012, Pages 358-368

  Kim, Ji Yeon ^a,b   Lee, Hye Seung ^a   Kim, Nayoung ^a,b   Shin, Cheol Min ^a,b   Lee, Sang Hyub ^a,b   Park, Young Soo ^a,b   Hwang, Jin Hyeok ^a,b   Kim, Jin Wook ^a,b   Jeong, Sook Hyang ^a,b   Lee, Dong Ho ^a,b   Park, Do Joong ^a   Kim, Hyung Ho ^a   Jung, Hyun Chae ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Cardia; Prevalence; Prognosis; Risk factors; Stomach neoplasm

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATROPHIC GASTRITIS; CANCER INVASION; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE CONTROL; FAMILY HISTORY; FEMALE; GASTRIC CARDIA CANCER; GASTROESOPHAGEAL REFLUX; HEARTBURN; HELICOBACTER INFECTION; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SOUTH KOREA; STOMACH CANCER;

ADULT; AGED; ASIA; CASE-CONTROL STUDIES; FEMALE; HEART NEOPLASMS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTOCYTOCHEMISTRY; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REPUBLIC OF KOREA; RISK FACTORS;

HELICOBACTER PYLORI;

EID: 84866268480     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2012.00958.x     Document Type: Article

References (67)

1. Ferlay J, Shin H, Bray F, et al. GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon
2. Jemal A, Center MM, DeSantis C, et al.Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010 Aug;19 (8):1893-907.
3. Bertuccio P, Chatenoud L, Levi F, et al.Recent patterns in gastric cancer: a global overview. Int J Cancer 2009;125:666-73.
4. Devesa SS, Fraumeni JF Jr. The rising incidence of gastric cardia cancer. J Natl Cancer Inst 1999;91:747-9.
5. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002;11:235-56.
6. Hundahl S, Phillips J, Menck H. The National Cancer Database Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth edition American Joint Committee on Cancer staing, proximal disease, and the "different disease" hypothesis. Cancer 2000;88:921-32.
7. Whitson BA, Groth SS, Li Z, et al.Survival of patients with distal esophageal and gastric cardia tumors: a population-based analysis of gastroesophageal junction carcinomas. J Thorac Cardiovasc Surg 2010;139:43-8.
8. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006;12:354-62.
9. Krejs GJ. Gastric cancer: epidemiology and risk factors. Dig Dis 2010;28:600-3.
10. Edge SB, Byrd DR, Compton CC, et al. editors. AJCC Cancer Staging Manual, 7th edn. New York: Springer-Verlag, 2009:117-26.
11. Derakhshan MH, Malekzadeh R, Watabe H, et al.Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut 2008;57:298-305.
12. Hansen S, Vollset SE, Derakhshan MH, et al.Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut 2007;56:918-25.
13. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53.
14. Steevens J, Schouten LJ, Goldbohm RA, et al.Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut 2010;59:39-48.
15. Kim HJ, Chang WK, Kim MK, et al.Dietary factors and gastric cancer in Korea: a case-control study. Int J Cancer 2002;97:531-5.
16. De Stefani E, Correa P, Boffetta P, et al.Dietary patterns and risk of gastric cancer: a case-control study in Uruguay. Gastric Cancer 2004;7:211-20.
17. McCullough ML, Robertson AS, Jacobs EJ, et al.A prospective study of diet and stomach cancer mortality in United States men and women. Cancer Epidemiol Biomarkers Prev 2001;10:1201-5.
18. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
19. Ishaq S, Jankowski JA. Barrett's metaplasia: clinical implications. World J Gastroenterol 2001;7:563-5.
20. Lindblad M, Rodriguez LA, Lagergren J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control 2005;16:285-94.
21. Dawsey SM, Mark SD, Taylor PR, et al.Gastric cancer and H. pylori. Gut 2002;51:457-8.
22. Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. IARC Sci Publ 1997; 7: 1-1240.
23. Correa P, Piazuelo MB. Natural history of Helicobacter pylori infection. Dig Liver Dis 2008;40:490-6.
24. Parkin DM. International variation. Oncogene 2004;23:6329-40.
25. Dent J, El-Serag HB, Wallander MA, et al.Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-7.
26. Global Infobase. http://www.who.int/infobase/report.aspx (accessed 4 May 2011).
27. Plummer M, Franceschi S, Munoz N. Epidemiology of gastric cancer. IARC Sci Publ 2004; (157):311-26.
28. Liu Y, Kaneko S, Sobue T. Trends in reported incidences of gastric cancer by tumour location, from 1975 to 1989 in Japan. Int J Epidemiol 2004;33:808-15.
29. Lee JY, Kim HY, Kim KH, et al.No changing trends in incidence of gastric cardia cancer in Korea. J Korean Med Sci 2003;18:53-7.
30. Rugge M, Correa P, Dixon MF, et al.Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002;16:1249-59.
31. Shin CM, Kim N, Lee HS, et al.Validation of diagnostic tests for Helicobacter pylori with regard to grade of atrophic gastritis and/or intestinal metaplasia. Helicobacter 2009;14:512-9.
32. Kim SY, Ahn JS, Ha YJ, et al.Serodiagnosis of Helicobacter pylori infection in Korean patients using enzyme-linked immunosorbent assay. J Immunoassay 1998;19:251-70.
33. Clark GW, Smyrk TC, Burdiles P, et al.Is Barrett's metaplasia the source of adenocarcinomas of the cardia?Arch Surg 1994;129:609-14.
34. Ruol A, Parenti A, Zaninotto G, et al.Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia. Cancer 2000;88:2520-8.
35. Crew KD, Neugut AI. Epidemiology of upper gastrointestinal malignancies. Semin Oncol 2004;31:450-64.
36. Pera M. Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction. Recent Results Cancer Res 2000;155:1-14.
37. Hayeck TJ, Kong CY, Spechler SJ, et al.The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus 2010;23:451-7.
38. Pera M. Trends in incidence and prevalence of specialized intestinal metaplasia, Barrett's esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg 2003;27:999-1008. discussion 6-8.
39. Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol 2001;30:1415-25.
40. Kim JI, Kim SG, Kim N, et al.Changing prevalence of upper gastrointestinal disease in 28 893 Koreans from 1995 to 2005. Eur J Gastroenterol Hepatol 2009;21:787-93.
41. Jung HK. Epidemiology of gastroesophageal reflux disease in Asia: a systematic review. J Neurogastroenterol Motil 2011;17:14-27.
42. Lee IS, Choi SC, Shim KN, et al.Prevalence of Barrett's esophagus remains low in the Korean population: nationwide cross-sectional prospective multicenter study. Dig Dis Sci 2010;55:1932-9.
43. Park JJ, Kim JW, Kim HJ, et al.The prevalence of and risk factors for Barrett's esophagus in a Korean population: a nationwide multicenter prospective study. J Clin Gastroenterol 2009;43:907-14.
44. Ho KY. From GERD to Barrett's esophagus: is the pattern in Asia mirroring that in the West?J Gastroenterol Hepatol 2011;26:816-24.
45. Bowrey DJ, Clark GW, Rees BI, et al.Outcome of oesophagogastric carcinoma in young patients. Postgrad Med J 1999;75:22-6.
46. Kang JM, Kim N, Yoo JY, et al.The role of serum pepsinogen and gastrin test for the detection of gastric cancer in Korea. Helicobacter 2008;13:146-56.
47. Li Y, Yang H, Cao J. Association between alcohol consumption and cancers in the Chinese population-a systematic review and meta-analysis. PLoS ONE 2011;6:e18776.
48. Shin CM, Kim N, Cho SI, et al.Association between alcohol intake and risk for gastric cancer with regard to ALDH2 genotype in the Korean population. Int J Epidemiol 2011;40:1047-55.
49. Parsonnet J, Friedman GD, Vandersteen DP, et al.Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
50. IARC Working Group on Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer. Schistosomes, liver Flukes and Helicobacter pylori. Lyon: IARC press, 1994;61:1-241.
51. Kamangar F, Dawsey SM, Blaser MJ, et al.Opposing risks of gastric cardia and noncardia GACs associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006;98:1445-52.
52. Cavaleiro-Pinto M, Peleteiro B, Lunet N, et al.Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes Control 2011;22:375-87.
53. Egi Y, Ito M, Tanaka S, et al.Role of Helicobacter pylori infection and chronic inflammation in gastric cancer in the cardia. Jpn J Clin Oncol 2007;37:365-9.
54. Yim JY, Kim N, Choi SH, et al.Seroprevalence of Helicobacter pylori in South Korea. Helicobacter 2007;12:333-40.
55. Limburg P, Qiao Y, Mark S, et al.Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer Inst 2001;93:226-33.
56. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999;130:883-90.
57. El-Serag HB, Graham DY, Satia JA, et al.Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol 2005;100:1243-50.
58. James PT, Leach R, Kalamara E, et al.The worldwide obesity epidemic. Obes Res 2001;9(Suppl 4):228S-33S.
59. Zhang ZF, Kurtz RC, Sun M, et al.Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomarkers Prev 1996;5:761-8.
60. Genta RM. Acid suppression and gastric atrophy: sifting fact from fiction. Gut 1998;43(Suppl 1):S35-8.
61. Ito M, Haruma K, Kamada T, et al.Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 2002;16:1449-56.
62. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-40.
63. Islami F, Sheikhattari P, Ren JS, et al.Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma--a systematic review and meta-analysis. Ann Oncol 2011;22:754-60.
64. Bruno L, Nesi G, Montinaro F, et al.Clinicopathologic findings and results of surgical treatment in cardiac adenocarcinoma. J Surg Oncol 2000;74:33-5.
65. Kim MA, Lee HS, Yang HK, et al.Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach. Cancer 2005;103:1439-46.
66. Deans C, Yeo MS, Soe MY, et al.Cancer of the gastric cardia is rising in incidence in an Asian population and is associated with adverse outcome. World J Surg 2011;35:617-24.
67. Saito H, Fukumoto Y, Osaki T, et al.Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach. World J Surg 2006;30:1864-9.